Major cardiovascular events cause about 80% of the total mortality in diabetic patients. It has been shown that diabetic patients have hyperactive platelets. It may be expected that aspirin, through its antiplatelet action, could change the risk for vascular events in people with diabetes. However, some data suggest that aspirin may be less effective than expected in preventing cardiovascular events in patients with diabetes. In this paper, we review the aspirin use in diabetics with respect to cardiovascular endpoints.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cardiovascular events
8
diabetic patients
8
[use aspirin
4
aspirin diabetic
4
diabetic patients]
4
patients] major
4
major cardiovascular
4
events 80%
4
80% total
4
total mortality
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!